The use of naniprus in patients with myocardial infarct complicated by acute left ventricular failure

Malinovskiĭ, I.V.

Likars'ka Sprava 1: 89-91

1993


ISSN/ISBN: 1019-5297
PMID: 8379148
Document Number: 409913
A study of 64 patients indicates Naniprus is a highly-effective drug for control left ventricular failure. Intravenous administration of naniprus (15-30 mg 2 times daily) is effective in the prophylaxis of recurrences of left ventricular failure in patients with myocardial infarction.

Document emailed within 1 workday
Secure & encrypted payments